Share Name Share Symbol Market Type Share ISIN Share Description
Destiny Pharma Plc LSE:DEST London Ordinary Share GB00BDHSP575 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 41.00p 39.00p 43.00p 41.00p 41.00p 41.00p 1,695 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -6.0 -11.9 - 18

Destiny Pharma Share Discussion Threads

Showing 51 to 74 of 75 messages
Chat Pages: 3  2  1
DateSubjectAuthorDiscuss
25/9/2019
16:23
The interesting point in the video above is that he estimated the phase III will cost about £30m to complete. The large companies are not interested in the antibiotics space and Destiny will struggle fund that sort of amount and if they do there will be massive dilution. And if it is approved will there be any uptake if a very cheap generic does the job just as well? Low margin, low sales and lots of time/funding still to go. I do hold a few but I still need to be convinced.
pdt
16/9/2019
09:58
As mentioned before. Biased and own more than i should but after watching that video, it has confirmed the reason i invested.Never like CEO interviews as i always find them believable and passionate about their companies future, but to me, this feels ok.Good luck to all that have stuck with it.Cheers
aspringo
16/9/2019
09:13
hTTps://youtu.be/JP7OHAWH3A4
cheshire man
10/9/2019
11:26
I'm biased as own too many, but i just have a feeling that this will end out ok.In the right space at the right time with tech that seems to work.Certainly no share buying advice intended.Fingers crossed for all holders.
aspringo
10/9/2019
11:09
That news bringing in a few buyers and up over 5% I see
cheshire man
20/8/2019
11:14
Garraway/CF stock went to WINS, they’ve been moving the stock on since then, I’d guess when they’re finished this will recover, no offer available from any of the other mm’s.
bumpa33
15/8/2019
14:22
`The holding on B'berg was held under the name "City Financial". When CF went pop, Garraway took on the fund. The fund was a UK Absolute Return by name but absolute disaster in terms of terrible fund performance and high volatility, so was wound up pdq. So the good news for DEST shareholders is that the recent kicking the stock has just had was/is a) technical and b) over and done with. Up to the company now to prove its worth.
johnniew156
15/8/2019
12:30
There's my answer. RNS.
cottoner
15/8/2019
07:41
A query wrt Garraway's holding. DEST have just under 44m shares in issue. 3% is just over 1.3m shares. I can't see any evidence of Garraway being/having been a major shareholder. Am I missing something?
cottoner
14/8/2019
13:36
Yes agreed johnniew. A further 125k sold this morning so possibly the last of the Garraway stake. No doubt there'll be an RNS to confirm v. soon.
gaiusgracchus
14/8/2019
11:24
Literally a couple of minutes after my posting, B'berg popped up with a delayed trade on the QR page. 1.4m shares were crossed at 35p at 15:56.18 yesterday, so yesterday's volume has been adjusted to 1,438,389 shares. In my view it would be extremely coinciental if this sale (of 1.4m shares) was not the balance of the 1.521943m Garraway stake that I am guessing was placed directly into market at least initially & ended up smashing the share price yesterday.
johnniew156
14/8/2019
11:01
Nice spot, makes sense. Thanks. Providing no upsets from the company themselves, it may be an opportunity, or then again?Good luck with any aim purchase.
aspringo
14/8/2019
10:59
Shareholders should be aware that the Garraway Capital former City of London Fund UK Absolute equity fund managed by David Crawford is being wound up. The fund held 1,521,943 shares of DEST according to Bloomberg as at 30.06.19. Could be coincidence, but a badly managed large sell order would explain the volume surge. hxxps://citywire.co.uk/funds-insider/news/troubled-absolute-return-fund-to-close-four-months-after-suspension/a1254614
johnniew156
14/8/2019
09:52
I'm going for a placing
mikeh30
14/8/2019
08:31
Just my tuppence worth on this share.I'm foolishly topping up and 3 of the purchase made today are mine tjough showing as sales.As far as i can see the story hasnt changed. So far delivered exactly as promised but now the share price is at a fraction of the IPO.Someone may know whats going on, but until then I'll take a chance and keep accumalating.Apologies for my naivety. Good luck all
aspringo
27/5/2019
22:11
Interesting what you say about the length of time this company has taken to get to where it is. I bought some of these after IPO. Not at the top thank goodness but still, I'm down a fair bit. I've subsequently decided to stop investing in biotech stocks. Just don't have the insight required. This doesn't add much to the discussion on Destiny (I'm still holding) but I wish I knew how to figure out if the drug is likely to be successful - in which case we should be piling in - or if it's going to be a dud. I don't know...clearly.
gaiusgracchus
16/4/2019
10:23
First bought into this pre IPO over 10 years ago. Its been a long time developing this so called super drug. Would see it 20 bag and a lot more if it did, but after all this time, I have strong doubts.
jack jebb
16/4/2019
10:15
updated Equity Development research following FY18 results reiterates attractions of their novel antimicrobials pipeline and raises fair value level . Note freely available here: https://www.equitydevelopment.co.uk/edreader/?ltkn=%5bID%5d&d=%3D%3DQO2UjM
edmonda
28/1/2019
09:42
Bought in here on Friday looks very a interesting company . This drug could revolutionise the antibiotics industry and trails seem to be going well . Sky was pushing this on the IPO so think they will be intrested in it. Never bought on a IPO and have been watching it for over a year . Think this has bottomed and starting to find some traction . GL DYOR
okidokicoki
08/1/2019
07:43
Looks like it will be bust soon enough
crowyogapose
25/10/2018
22:08
If there is any value here and China Medical bid, try and take paper. They have been a 20 bagger pour moi !
superadams
25/10/2018
20:56
15p target
opodio
05/10/2018
11:54
new analysis on pipeline's development and expansion, with increased fair value as a result (a multiple of current share price). Plenty of news expected in coming weeks, too. Note freely accessible here: https://www.equitydevelopment.co.uk/edreader/?ltkn=5f3dec7ebec4cbdaf80bd7d872a074b0AvbosF0F&d=%3D%3DAO4QjM
edmonda
05/9/2018
11:14
https://www.edisoninvestmentresearch.com/research/report/destiny-pharma/preview/?utm_source=edison&utm_medium=EQUISOLVE_press_release&utm_campaign=DEST_04092018
mikeh30
Chat Pages: 3  2  1
Your Recent History
LSE
DEST
Destiny Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191020 12:06:58